Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-NH-PEG2-COOH is a conjugate synthesized as an E3 ligase ligand-linker, incorporating the cereblon ligand from Thalidomide and a linker commonly used in [PROTAC] technology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | Inquiry | Backorder | Backorder | |
| 100 mg | Inquiry | Backorder | Backorder |
| Description | Thalidomide-NH-PEG2-COOH is a conjugate synthesized as an E3 ligase ligand-linker, incorporating the cereblon ligand from Thalidomide and a linker commonly used in [PROTAC] technology. |
| In vitro | PROTACs contain two ligands connected by a linker: one for an E3 ubiquitin ligase and the other for the target protein. They leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| Synonyms | Thalidomide-NH-PEG2-COOH |
| Molecular Weight | 433.417 |
| Formula | C20H23N3O8 |
| Cas No. | 2412056-45-0 |
| Relative Density. | 1.456 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.